Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Haemophilus influenzae Rd KW20 has virulence properties.
Daines DA, Cohn LA, Coleman HN, Kim KS, Smith AL. Daines DA, et al. Among authors: coleman hn. J Med Microbiol. 2003 Apr;52(Pt 4):277-282. doi: 10.1099/jmm.0.05025-0. J Med Microbiol. 2003. PMID: 12676864
Cervical Microbiome and Response to a Human Papillomavirus Therapeutic Vaccine for Treating High-Grade Cervical Squamous Intraepithelial Lesion.
Ravilla R, Coleman HN, Chow CE, Chan L, Fuhrman BJ, Greenfield WW, Robeson MS, Iverson K, Spencer H 3rd, Nakagawa M. Ravilla R, et al. Among authors: coleman hn. Integr Cancer Ther. 2019 Jan-Dec;18:1534735419893063. doi: 10.1177/1534735419893063. Integr Cancer Ther. 2019. PMID: 31833799 Free PMC article. Clinical Trial.
Human papillomavirus type 16 viral load is decreased following a therapeutic vaccination.
Coleman HN, Greenfield WW, Stratton SL, Vaughn R, Kieber A, Moerman-Herzog AM, Spencer HJ, Hitt WC, Quick CM, Hutchins LF, Mackintosh SG, Edmondson RD, Erickson SW, Nakagawa M. Coleman HN, et al. Cancer Immunol Immunother. 2016 May;65(5):563-73. doi: 10.1007/s00262-016-1821-x. Epub 2016 Mar 15. Cancer Immunol Immunother. 2016. PMID: 26980480 Free PMC article. Clinical Trial.
A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3.
Greenfield WW, Stratton SL, Myrick RS, Vaughn R, Donnalley LM, Coleman HN, Mercado M, Moerman-Herzog AM, Spencer HJ, Andrews-Collins NR, Hitt WC, Low GM, Manning NA, McKelvey SS, Smith D, Smith MV, Phillips AM, Quick CM, Jeffus SK, Hutchins LF, Nakagawa M. Greenfield WW, et al. Among authors: coleman hn. Oncoimmunology. 2015 May 27;4(10):e1031439. doi: 10.1080/2162402X.2015.1031439. eCollection 2015 Oct. Oncoimmunology. 2015. PMID: 26451301 Free PMC article.
Cross-Reactivity, Epitope Spreading, and De Novo Immune Stimulation Are Possible Mechanisms of Cross-Protection of Nonvaccine Human Papillomavirus (HPV) Types in Recipients of HPV Therapeutic Vaccines.
Nakagawa M, Greenfield W, Moerman-Herzog A, Coleman HN. Nakagawa M, et al. Among authors: coleman hn. Clin Vaccine Immunol. 2015 Jul;22(7):679-87. doi: 10.1128/CVI.00149-15. Epub 2015 May 6. Clin Vaccine Immunol. 2015. PMID: 25947147 Free PMC article. Review.
41 results